Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/14/2013

Company Name Symbol %Change
INTEROIL COR IOC
9.57%
INFORMATION III
9.47%
A M R CP AAMRQ
6.83%
SCIENTIFIC L SCIL
5.26%
PACER INTL I PACR
5.23%
Walgreens extends agreement as a CVS Caremark Network Provider

Print Share

May 14, 2013 (M2 EQUITYBITES via COMTEX) -- Drugstore chain Walgreens (WAG) (NYSE:WAG) announced on Monday the extension of its agreement as a network pharmacy provider in the CVS Caremark pharmacy benefit management (PBM) national retail network.

Financial details and other confidential terms of the agreement were not disclosed.

According to the company, this multi-year agreement meets its business objectives, remains consistent with its principles of receiving predictable and fair reimbursement for the services and value it provides and helps drive cost-effective pricing for payers and patients.

Comments on this story may be sent to info@m2.com

(C)1994-2013 M2 COMMUNICATIONS http://www.m2.com

**********************************************************************

As of Friday, 05-10-2013 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated an UPTREND on
05-02-2012 for CVS @ $45.54.

As of Friday, 05-10-2013 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated a DOWNTREND on
05-14-2012 for WAG @ $32.95.

For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2013 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.